Order Article Reprints

Arranz MJ, Salazar J, Bote V, Artigas-Baleri A, Serra-LLovich A, Triviño E, Roige J, Lombardia C, Cancino M, Hernandez M, et al. Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers. Pharmaceutics. 2022; 14(5):999. https://doi.org/10.3390/pharmaceutics14050999

Arranz, Maria J., Juliana Salazar, Valentin Bote, Alicia Artigas-Baleri, Alexandre Serra-LLovich, Emma Triviño, Jordi Roige, Carlos Lombardia, Martha Cancino, Marta Hernandez, and et al. 2022. "Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers" Pharmaceutics 14, no. 5: 999. https://doi.org/10.3390/pharmaceutics14050999

Arranz, M. J., Salazar, J., Bote, V., Artigas-Baleri, A., Serra-LLovich, A., Triviño, E., Roige, J., Lombardia, C., Cancino, M., Hernandez, M., Cendros, M., Duran-Tauleria, E., Maraver, N., & Hervas, A. (2022). Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers. Pharmaceutics, 14(5), 999. https://doi.org/10.3390/pharmaceutics14050999